CETYA THERAPEUTICS, INC.
Fort Collins, CO · Biotech · Private
CT-101, a selective HDAC inhibitor molecule that induces fetal hemoglobin expression to treat β-hemoglobinopathies
cetyatherapeutics.com →- Grants
- $1.9M
- 4 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 3
- 1 granted · 2 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20172018201920202021
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Novel HDAC Inhibitors for Treatment of Hemoglobinopathies | $241,742 | |
| Federal grant | Department of Health and Human Services · Phase II · In Vivo Studies of a Novel HDAC Inhibitor for Treating Hemoglobin Disorders | $1,073,855 | |
| Federal grant | Department of Health and Human Services · Phase II · In Vivo Studies of a Novel HDAC Inhibitor for Treating Hemoglobin Disorders | $24,589 | |
| Federal grant | Department of Health and Human Services · Phase II · In Vivo Studies of a Novel HDAC Inhibitor for Treating Hemoglobin Disorders | $550,046 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 3346 | FLASHPOINT THE ACADEMY OF MEDIA ARTS & SCIENCES LLC | — | $1.0M |
| 3347 | MAVERIX BIOMICS, INC. | — | $8.0M |
| 3348 | Attovia Therapeutics | — | — |
| 3349 | CETYA THERAPEUTICS, INC. | — | — |
| 3350 | Aethl Bio, Inc. | — | $1.6M |
| 3351 | PRIMORDIAL GENETICS, INC. | — | $1.6M |
| 3352 | RADIA TECHNICAL IMAGING LLC | — | $37K |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Synthesis Of Structural Analogs Of Largazole And Associated Compoundsgranted
- Synthesis Of Structural Analogs Of Largazole And Associated Compoundsapplication
- Synthesis Of Structural Analogs Of Largazole And Associated Compoundsapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.